.jpg)
.png)
All
According to the second part of the joint scientific statement by the National Lipid Association (NLA), American Society for Metabolic and Bariatric Surgery (ASMBS), and Obesity Medicine Association (OMA), bariatric surgery improves multiple cardiovascular risk factors, including blood... more
There has been robust participation among SWLA members in the National Lipid Association activities and outstanding contributions to the field of lipidology! Here are just a few highlights of what our productive group achieved in 2023! Planned by SWLA leadership, Christie Ballantyne, MD; Nicole... more
The National Lipid Association is excited to announce a month-long extravaganza of virtual education, LipidPALOOZA, launching this September to celebrate National Cholesterol Education Month. There will be a variety of activities spread throughout the entire month and best of all, they will be... more
As President-Elect of the Pacific Lipid Association (PLA), I am super excited to share with you that the 2023 year is off to a great start! This issue of LipidSpin is a collaboration between PLA and SWLA with a focus on Pushing Boundaries. My immense gratitude goes out to all who have contributed.... more
In keeping with the theme of this issue of the LipidSpin, this Specialty Corner is devoted to advice for the practicing clinician who has to make daily decisions on how best to protect his/her patients from cardiovascular disease. It seems since the 2013 publication of the American College of... more
Emphasizes the Importance of LDL-Cholesterol Monitoring, LDL Goal Attainment and Shared Decision Making Between Patients and Provider NEW YORK — Yesterday, the National Lipid Association (NLA) released the Full Report of its Part One Recommendations for Patient-Centered... more
Inclisiran (Leqvio; Novartis) is now the first small interfering RNA (siRNA) therapy to be approved by the FDA to reduce low-density lipoprotein cholesterol (LDL-C). Inclisiran was previously approved in the EU on 9 December 2020 for use in adults with primary hypercholesterolemia (heterozygous... more
Take your first step towards long-term career enhancement as a Lipid Scholarship Program participant. National Lipid Association Lipid Scholarship Program Lipid Scholarship Program applications for 2026 are now closed. To apply please read the following messages and... more